Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.

Iain B. McInnes,Jaclyn K. Anderson,Marina Magrey,Joseph F. Merola,Yi Liu,Mitsumasa Kishimoto,Sławomir Jeka,César Pacheco-Tena,X Wang,Liang Chen,P Zueger,John Liu,Aileen L. Pangan,Frank Behrens

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.

2021

Iain B. McInnes
Jaclyn K. Anderson
Marina Magrey
Joseph F. Merola
Yi Liu
Mitsumasa Kishimoto
Sławomir Jeka
César Pacheco-Tena
X Wang
Liang Chen
P Zueger
John Liu
Aileen L. Pangan
Frank Behrens

Abstract Background The Janus kinase inhibitor upadacitinib is a potential treatment for psoriatic arthritis. The efficacy and safety of upadacitinib as compared with adalimumab, a tumor necrosis f...

Keywords:

Janus kinase inhibitor
Adalimumab
Dermatology
Tumor necrosis factor alpha
Medicine
Psoriatic arthritis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations